Abstract
The effects of intraperitoneal administration of (S)-4-amino-5-fluoropentanoic acid, a mechanism-based covalent inactivator of γ-aminobutyric acid transaminase (GABA-T), on whole brain GABA metabolism in mice were investigated. A dose-dependent and time-dependent irreversible inactivation of GABA-T was observed with a concomitant increase in whole brain GABA levels. The compound exhibited no in vitro nor in vivo time-dependent inhibition of glutamate decarboxylase (GAD), alanine transaminase, or aspartate transaminase (Asp-T). It was, however, a potent competitive reversible inhibitor of GAD and a weak competitive inhibitor of Asp-T. The chloro analogue, (S)-4-amino-5-chloropentanoic acid, was ineffective.
Original language | English (US) |
---|---|
Pages (from-to) | 2717-2723 |
Number of pages | 7 |
Journal | Life Sciences |
Volume | 32 |
Issue number | 24 |
DOIs | |
State | Published - Jun 13 1983 |
Funding
We thank Paul Sumner for determining the mouse brain GABA concentrations and the National Institutes of Health (Grant NS 15703) for financial support of this work.
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- General Biochemistry, Genetics and Molecular Biology